YouShi Medical Secures Tens of Millions in New Funding to Advance Global Strategy in Orthopedic Joint Implants

VCBeat learned第一时间 that Youshi Medical Technology (Suzhou) Co., Ltd., an innovative enterprise in the field of orthopedic artificial joints in ChinaYoushi Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "Youshi Medical")Announced the completion of a new round of financing worth tens of millions, with this round of investment led bySu High-tech FinanceAndSuzhou Medical Device Industry Development GroupCo-led Investment, SND Co., Ltd.AndSuzhou PufeiParticipate in follow-on investment. This round of financing will be used for the expansion of Youshi Medical's international and domestic business markets and the continuous development of the company's innovative products.

Youshi Medical Technology (Suzhou) Co., Ltd. was established in July 2014 and is located in the Suzhou New District, Jiangsu Province. It is a national high-tech enterprise specializing in the research, development, production, and sales of orthopedic artificial joint implants. The founding team and the German management team both come from senior executives of internationally and domestically renowned orthopedic companies, possessing extensive experience in the orthopedic industry and management.

The company's products have currently obtained EU CE certification, NMPA, and product registration certificates in more than a dozen countries and regions internationally, with clinical implantation successfully completed. The company has achieved an international layout of "global R&D, made in China, global sales" and is committed to building the most internationally competitive Chinese orthopedic artificial joint company.

aap Joints GmbH, a German-based company located in Berlin, is a wholly-owned subsidiary of Youshi Medical Technology (Suzhou) Co., Ltd. Since 2000, it has been providing high-quality artificial joint products to the European market. The reliability and stability of its products have been fully validated by the market, consistently embodying the trusted qualities associated with German manufacturing.

The Mebio knee product series of the company has a successful clinical application history of over 20 years, and the VarioLoc hip product series has a history of more than 10 years. During its development, the company has continuously expanded its product range and successfully developed cutting-edge innovative products such as all-ceramic joints, 3D-printed hip joints, VE highly cross-linked liners, and dual-mobility total hips. All products have obtained EU CE certification. Youshi Medical Technology (Suzhou) Co., Ltd has introduced its high-quality and reliable products to China and localized production there. The product quality is entirely manufactured according to German standards and sold globally under the "aap Joints" brand.

Founder and CEO of Youshi Medical, Huang FeipengExpressed: "We are very grateful to this round of investors for their recognition and trust in Youshi Medical, supporting and contributing to the next phase of rapid development for Youshi Medical. Since its establishment, Youshi Medical has been committed to 'helping people restore a world of free movement.'’With a clear vision, we continuously strive forward, creating unique value for Youshi Medical. Our German subsidiary, aap Joints, is experiencing rapid business growth across more than ten countries in Europe, Southeast Asia, and the Middle East, with positive clinical feedback, laying a solid foundation for the company’s sustained high-speed development. In 2022, we obtained six NMPA product registrations, including total hip and total knee replacements. I am delighted to introduce high-quality artificial joint products into the Chinese market, benefiting a wide range of patients in China. Building on our existing product lines, we will focus on the research and innovation of intelligent and digital orthopedic products as well as premium anti-infection orthopedic implants. Our goal is to address real clinical pain points and continuously meet actual clinical needs, providing comprehensive artificial joint solutions.”

Assistant General Manager of Suzhou Jinhesheng Holdings Co., Ltd., Dong Min"Youshi Medical is an innovative orthopedic medical device company with strong beliefs, determination, and resilience. Its founding team and management personnel possess extensive industry experience and have a profound and unique understanding of both the domestic and international orthopedic markets. The company has a clear development orientation, a well-defined strategy that has been consistently implemented. Internationalization is an important pathway for domestic medical device companies to enhance their competitiveness. After years of deep cultivation, Youshi Medical has successfully established a dual-circulation layout in the domestic and international markets, making it a rare Chinese orthopedic artificial joint enterprise with a truly international business platform. I believe that as Youshi Medical continues to expand its innovative product lines and promote them globally through its international business platform, the company will gain continuous momentum for development."”

Wang Ping, Chairman of Suzhou Medical Device Industry Development GroupStated: "We are very pleased to participate in this round of investment in Youshi Medical. Youshi Medical has a solid business foundation and currently holds the highest number of 16 EU CE product registrations among domestic orthopedic companies. Its products cover cutting-edge innovative solutions for primary and revision hip and knee joints, including full ceramic joints, 3D-printed hip and knee joints, VE highly cross-linked liners, dual-mobility total hips, and more. The company’s product line is comprehensive, comparable to leading international joint manufacturers. Especially after the EU implemented the new MDR product certification, the difficulty of obtaining certifications for new artificial joint products will significantly increase. Youshi Medical has already gained an excellent first-mover advantage in the international market. Currently, the potential for import substitution in China's artificial joint market is enormous. Based on the six domestic registrations Youshi Medical has already obtained, it will secure four additional registrations and begin market promotion in 2023. We have high confidence in the competitiveness of Youshi Medical’s high-quality products, which have been fully validated in international markets, within the domestic market. They are bound to become a new major force in China’s artificial joint market."”

Reorganized in November 2018, Suzhou New District Financial Holdings originated from "Jiangsu Su High-Tech Venture Capital Co., Ltd.," the first joint-stock venture capital company established in Jiangsu Province in 2000. With a current registered capital of 5.1 billion yuan, it is a state-owned financial holding group directly under the Suzhou New District Management Committee. Suzhou New District Financial Holdings oversees three major subsidiary groups (Suzhou New District Venture Capital Investment Group Co., Ltd., Suzhou New District Innovation Technology Investment Management Co., Ltd., and Taihu Golden Valley (Suzhou) Development Co., Ltd.), forming a financial service system that promotes coordinated development and integrated interaction in equity investment, non-banking finance, and multi-level capital market services, striving to build a first-class modern financial holding enterprise.

Medpark (Jiangsu Medical Device Technology Park), operated by Suzhou Medical Device Industry Development Group, is a national-level medical device technology park jointly built by Suzhou New District and the Suzhou Institute of Biomedical Engineering Technology of the Chinese Academy of Sciences. The operating entity, Suzhou Medical Device Industry Development Group Co., Ltd., is responsible for coordinating resources in Suzhou New District. Relying on three core capabilities—"carrier development and construction, park operation, and industrial investment"—the park focuses on the development of the medical device industry. The construction of the park started in 2009, with a total planned area of 2 square kilometers. Currently, it has 600,000 square meters of self-built carrier space. The fourth-phase innovation base, covering 152 mu, has already broken ground, while the fifth and sixth phases are in the planning stage. Medpark gathers innovative domestic and international medical device companies and industry leaders, many of whose technical achievements are the first of their kind in China and leading in the industry. Medpark will adhere to the development philosophy of "integration and innovation" and adopt an operational model that emphasizes "ecological construction, industrial clustering, fund-based investment promotion, professional services, market-oriented platforms, self-owned carriers, securitized assets, and digitalized operations." It aims to establish itself as the top brand in China’s medical device industry and create a 100-billion-yuan medical device industrial base.